Share on PinterestOmega-3 supplements combined with strength training could boost athletic performance and improve heart and brain health. Lan Zhang/Getty Images Omega-3 supplements combined with weightlifting could result in improvements to strength and health. A new study suggests that incorporating omega-3s into a strength training regimen positively impacts heart and brain health and can lead […]
Read MoreAuthor: sugaradmin
2154-LB: Rapid Appearance of Newly Synthesized Insulin and C-Peptide in Plasma (Reduced Residence Time in β-Cells) Is a Noninvasive Measure of Loss of Insulin Reserve in ZDF Rats
Introduction and Objective: T2D evolves through progressive loss of β-cell secretory capacity and insulin reserve. Non-invasive detection of insulin depletion in β-cells has not been possible. We tested a flux-based method for identifying reduced β-cell insulin stores non-invasively. The time for newly synthesized Ins and C-P to appear and become fully labeled in plasma reveals […]
Read More275-OR: Change in Hypoglycemia Fear and Frequency with the Use of Automated Insulin Delivery—A Prospective Analysis of the Type 1 Diabetes Better Registry
Introduction and Objective: Automated insulin delivery (AID) is expected to reduce the burden of hypoglycemia including fear of hypoglycemia (FOH) in type 1 diabetes (T1D). This study aimed to evaluate the change in hypoglycemia fear survey-II (HFS-II) scores and hypoglycemia frequency after AID initiation in usual-living conditions.Methods: Adults (≥18years) living with T1D from the Canadian […]
Read More2153-LB: Insulin and C-peptide Labeling Kinetics in Islets vs. Plasma of ZDF Rats
Introduction and Objective: We asked whether insulin (Ins) and C-peptide (C-P) kinetics (β-cell residence times [RT}} measured from islets vs plasma correlate closelyMethods:2H2 O was given for 3 – 18 hr to 32 female ZDF rats fed high fat diet (to induce T2D) or chow. RT of Ins and C-P were measured by high-resolution mass […]
Read More270-OR: Risk of Severe Hypoglycemia Associated with Concomitant Use of Sulfonylurea and Amiodarone
Introduction and Objective: Sulfonylureas (SU), commonly used for type 2 diabetes, are metabolized by liver cytochrome P450 2C9 (CYP 2C9), which is inhibited by amiodarone. Given their frequent co-administration in patients with diabetes and arrhythmia, we evaluated the risk of severe hypoglycemia associated with their concomitant use.Methods: Using South Korean health insurance claims data (2010-2022), […]
Read More2152-LB: Prediabetes Phenotypes Defined by Glucose-Stimulated Insulin Response Using Hyperglycemic Clamp in Healthy Young People
Introduction and Objective: Prediabetes, often classified by static glucose measures, limits identification of impaired beta-cell function beyond response to prevailing insulin sensitivity. We implemented hyperglycemic clamps (HG) to classify prediabetes phenotypes based on stimulated insulin response.Methods: We screened healthy individuals (n=2500, 18-45 yrs, BMI 18.5-25 kg/m2) and recruited (37 normal glycemia, NG; 63 prediabetes, preD) […]
Read More1899-LB: Diabetic Foot Care—Clinical Profile and Self-Reported Knowledge among Patients with Diabetes Attending a Public Care Centre in the Northeast of Brazil
Introduction and Objective: The diabetes foot disease (DFD) is a prevalent condition that challenges the health system. Diabetes education help people gain skills for self-care and the assessment of the individual patient’s knowledge of diabetes can make it more effective. This study aims to evaluate the clinical, sociodemographic profile and the knowledge about diabetes among […]
Read More2151-LB: The Hypothalamic Epitranscriptome of Prader-Willi Syndrome (PWS) during Early Development Shows Alterations to Insulin Signaling and Homeostatic Response
Introduction and Objective: We are investigating the CNS basis of hyperphagia and disrupted energy homeostasis in PWS using human cellular models of brain development. The homeostatic response to nutrient status and signaling appears dysregulated in PWS, and we hypothesize that altered epitranscriptomic fine-tuning of hypothalamic neurons is involved. The biochemical modifications to RNA that comprise […]
Read More2036-LB: How CGM Use Affects Diabetes-Related Attitudes and Behaviors in People with T2D—A Qualitative Investigation
Introduction and Objective: A recent randomized controlled trial demonstrated greater improvements in patient-reported engagement with diabetes self-care and glycemic control in new Freestyle Libre 3 (FSL3) users than standard glucose monitor users. We aimed to qualitatively explore how continuous glucose monitoring (CGM) led to these behavioral and glycemic changes.Methods: Adults with T2D on basal or […]
Read More2150-LB: Dissecting Incretin-Mediated Modulation of Hypothalamic Feeding Circuit
Introduction and Objective: Analogs of the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) have become mainstays of obesity and diabetes management. However, the physiologic role of incretin hormones in controlling appetite and how incretin-mimetic drugs suppress caloric intake remain unclear.Methods: Hunger-promoting AgRP-expressing hypothalamic neurons are important in regulating food intake. Therefore, we […]
Read More